Financing Overview - In the week from December 29 to January 4, Shanghai saw a total of 30 financing events, with 17 disclosing their amounts, totaling 3.658 billion yuan, which is an increase of 14 events compared to the previous week [4] - The highest number of financing events occurred in Pudong New District with 8 events, followed by Yangpu District and Jiading District with 4 events each [4] - A significant financing event in the integrated circuit sector was reported in Changning, amounting to 2.57 billion yuan [4] Company Dynamics - New Micro Group completed a strategic financing round of 2.57 billion yuan on December 30, with investments from multiple funds including the National Green Development Fund and Shanghai International Group [13] - Dongsheng Fusion secured several hundred million yuan in angel round financing on January 4, backed by prominent investors such as IDG Capital and Sequoia China [15] - Borui Biotech completed over 100 million yuan in A-round financing on December 29, led by Qianji Capital [17] - Chenxin Technology received a strategic financing round of over 100 million yuan on December 31, with investments from Changjiang Innovation and Jinpu Intelligent [19] Industry Focus - The healthcare sector had 7 financing events this week, focusing on pharmaceuticals and medical devices [21] - Microinvasive Heart's VitaFlow Liberty® system received approval for market entry in Morocco on December 29, while Qilu Pharmaceutical's global R&D headquarters project commenced in Zhangjiang [21] - The Shanghai government aims to enhance the international competitiveness of local biopharmaceutical companies, targeting over 50 billion yuan in exports and 2-3 companies achieving over 10 billion yuan in overseas sales by 2027 [21]
30起！上海融资大爆发 | 融资周报（2026年第1期）